Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: A case report

摘要

Retinal vasoproliferative tumors (VPRTs) are highly vascularised masses of the neuro-sensory retina. These benign tumours have been classified as idiopathic or secondary. This secondary type has been associated with predisposing lesions such as pars planitis or other inflammatory events [1]. In some cases, visual acuity may be profoundly impaired owing to progressive exudation involving the macular region with macular exudation or cystoid macular edema Interleukin (DL)-6 receptor blockade using tocilizumab (TCZ) proved effective for many autoimmune or inflammatory diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis (JIA), and large-vessel vasculitides [2]. Here, we present a case of intractable case of VPRT secondary to JIA-associated uveitis who favourably responded to TCZ.